Used in biochemical research as a glycosylated hydroxamic acid derivative, this compound shows potential in enzyme inhibition studies, particularly targeting metalloenzymes involved in cellular signaling and disease progression. Its structure allows interaction with glycosidase enzymes and histone deacetylase (HDAC) families, making it useful in the development of therapeutic agents for cancer and inflammatory diseases. It is also employed in the design of prodrugs due to its enhanced solubility and cell permeability conferred by the glucopyranosyl group. Additionally, the naphthalenyloxy and hydroxyamino functionalities contribute to fluorescent tagging applications in cellular imaging and molecular tracking studies.